Literature DB >> 9845591

Intractable ascites following surgery for gastric carcinoma.

K Kumagai1.   

Abstract

Over the past 11 years, I have experienced a few patients with intractable ascites after extended radical surgery for gastric carcinomas, which accounted for 1.0% (4 of 394) of all gastric carcinomas resected in our institute. These 4 patients underwent total or subtotal gastrectomy with extended lymphadenectomy, including the lymph nodes of the hepatoduodenal ligament. Histopathologic examination of an intraoperative liver biopsy specimen revealed chronic hepatitis or liver cirrhosis. The characteristics of the ascites led me to conclude that the ascites comprised liver lymphatic fluid. Surgeons must recognize that intractable ascites due to leakage of liver lymphatic fluid after gastrectomy with extended lymphadenectomy is likely to occur in patients with chronic hepatitis or liver cirrhosis.

Entities:  

Mesh:

Year:  1998        PMID: 9845591     DOI: 10.1159/000018620

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  4 in total

1.  Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection.

Authors:  Jun Ho Lee; Junuk Kim; Jae Ho Cheong; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

2.  Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction.

Authors:  Keun Won Ryu; Jun Ho Lee; Young Woo Kim; Joong-Won Park; Jae-Moon Bae
Journal:  World J Surg       Date:  2005-05       Impact factor: 3.352

3.  Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study.

Authors:  Hyun Joo Jang; Jung Han Kim; Hun Ho Song; Kyung Hee Woo; Mi Kim; Sea Hyub Kae; Jin Lee; Ji Wong Cho; Jung Hun Kang; Soon Il Lee; Soo Jung Gong; Jung Ae Lee; Dae Young Zang
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

4.  Treatment selection for gastric cancer with portal hypertension: clinical management.

Authors:  Zhou-Xiang Jin; Yong-Yong Ma; Xiang-Yu Wang; Li-Jun Li; Zhi-Qiang Zheng
Journal:  Gastric Cancer       Date:  2013-06-28       Impact factor: 7.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.